Randomized pilot trial comparing tolvaptan with furosemide on renal and neurohumoral effects in acute heart failure

AIMS: Loop diuretics are first‐line medications for congestive heart failure (CHF); however, they are associated with serious adverse effects, including decreased renal function, and sympathetic nervous and renin–angiotensin system activation. We tested whether tolvaptan, a vasopressin V2‐receptor a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:ESC Heart Fail
Autors principals: Jujo, Kentaro, Saito, Katsumi, Ishida, Issei, Furuki, Yuho, Kim, Ahsung, Suzuki, Yuki, Sekiguchi, Haruki, Yamaguchi, Junichi, Ogawa, Hiroshi, Hagiwara, Nobuhisa
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2016
Matèries:
Original Research Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5071712/
https://ncbi.nlm.nih.gov/pubmed/27818782
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12088
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars